| Press Release: Strand Announces Collaboration with Bio-Rad |
|
August 10, 2004: Strand Genomics
announced today that it
has entered into an collaborative agreement with Bio-Rad Laboratories, Inc. to
integrate its predictive human pharmacokinetic models in
Bio-Rad's KnowItAll® platform for in silico ADME/Tox assessment.
|
| Feature in Current Drug Discovery |
|
A feature titled
'In silico ADME-Tox prediction: The more, the merrier' by Gregory Banik, Bio-Rad Laboratories,
appears in Current Drug Discovery magazine. The feature describes Bio-Rad's parnerships, including that with Strand Genomics
in producing the KnowItAll® platform.
|
| Dr. Kas Subramanian speaks at Predictive ADME conference |
|
Meet us at Predictive ADME Conference
17-18 November, Boston
Speaker: Dr. Kas Subramanian, CSO, Strand Genomics
on Predicting Pharmacokinetics of a Drug using Machine Learning
|
Dr. Kas Subramanian speaks at Evaluating Preclinical Drug Safety conference |
|
Meet us at Evaluating Preclinical Drug Safety conference
June 6-8, 2005 ,Boston, MA
Speaker: Dr. Kas Subramanian, CSO, Strand Genomics
on Learning from the Past - Building Models to Predict ADME and Toxicity
|
